We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
+5.85%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+604.63%
AUM
$79.7B
AUM Growth
-$3.54B
(-4.3%)
Cap. Flow
-$8.2B
Cap. Flow
% of AUM
-10.29%
Top 10 Holdings %
Top 10 Hldgs %
14.16%
Holding
2,085
New
185
Increased
629
Reduced
928
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$392M |
| 2 |
Verizon
VZ
|
+$361M |
| 3 |
Occidental Petroleum
OXY
|
+$354M |
| 4 |
Walt Disney
DIS
|
+$162M |
| 5 |
MON
Monsanto Co
MON
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$4.92B |
| 2 |
AstraZeneca
AZN
|
+$621M |
| 3 |
SLM Corp
SLM
|
+$355M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$290M |
| 5 |
SPLS
Staples Inc
SPLS
|
+$278M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.37% |
| 2 | Technology | 14.88% |
| 3 | Healthcare | 12.02% |
| 4 | Industrials | 10.74% |
| 5 | Energy | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEE.PRP
1276
DELISTED
NEXTERA ENERGY INC EQUITY UNIT
NEE.PRP
| $1.43M | ﹤0.01% |
25,000
| – | – |
|
|
OREX
1277
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $1.42M | ﹤0.01% |
22,990
-23,299
| -50% | -$1.35M |
|
1278
Genuine Parts
GPC
$18.1B
| $1.41M | ﹤0.01% |
16,019
+1,507
| +10% | +$130K |
|
1279
Lennox International
LII
$15.4B
| $1.38M | ﹤0.01% |
15,417
-2,738
| -15% | -$238K |
|
1280
Antero Resources
AR
$10.6B
| $1.38M | ﹤0.01% |
21,021
-2,044
| -9% | -$130K |
|
1281
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$718M
| $1.37M | ﹤0.01% |
21,060
| – | – |
|
|
CYTR
1282
DELISTED
CytRx Corp
CYTR
| $1.37M | ﹤0.01% |
54,535
-5,632
| -9% | -$128K |
|
|
ARNA
1283
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.36M | ﹤0.01% |
23,213
-2,397
| -9% | -$151K |
|
1284
iShares MSCI Taiwan ETF
EWT
$10.6B
| $1.36M | ﹤0.01% |
43,000
-22,000
| -34% | -$660K |
|
|
VTLE
1285
DELISTED
Vital Energy
VTLE
| $1.36M | ﹤0.01% |
2,194
-190
| -8% | -$108K |
|
1286
Consumer Portfolio Services
CPSS
$199M
| $1.36M | ﹤0.01% |
178,155
-42,740
| -19% | -$315K |
|
|
KSU
1287
DELISTED
Kansas City Southern
KSU
| $1.35M | ﹤0.01% |
12,572
-4
| -0% | -$413 |
|
|
BRFS
1288
DELISTED
BRF SA
BRFS
| $1.34M | ﹤0.01% |
55,272
-2,400
| -4% | -$54.3K |
|
1289
Ross Stores
ROST
$81.2B
| $1.34M | ﹤0.01% |
40,594
+16,098
| +66% | +$553K |
|
|
MDCO
1290
DELISTED
Medicines Co
MDCO
| $1.34M | ﹤0.01% |
46,170
-3,530
| -7% | -$94.3K |
|
|
TECD
1291
DELISTED
Tech Data Corp
TECD
| $1.32M | ﹤0.01% |
21,197
-15,230
| -42% | -$944K |
|
|
KOG
1292
DELISTED
KODIAK OIL & GAS CORP
KOG
| $1.32M | ﹤0.01% |
91,056
-195,909
| -68% | -$2.55M |
|
|
XIN
1293
DELISTED
Xinyuan Real Estate
XIN
| $1.32M | ﹤0.01% |
31,264
-3,641
| -10% | -$155K |
|
1294
Stanley Black & Decker
SWK
$15.6B
| $1.3M | ﹤0.01% |
14,848
+53
| +0.4% | +$4.52K |
|
1295
Cytokinetics
CYTK
$10.7B
| $1.28M | ﹤0.01% |
267,460
-43,393
| -14% | -$265K |
|
|
MLU
1296
DELISTED
METLIFE, INC. COM EQUITY UNIT
MLU
| $1.28M | ﹤0.01% |
40,000
| – | – |
|
1297
Horace Mann Educators
HMN
$2.1B
| $1.27M | ﹤0.01% |
40,626
-1,532
| -4% | -$45.4K |
|
1298
Williams-Sonoma
WSM
$29.2B
| $1.26M | ﹤0.01% |
35,228
-67,998
| -66% | -$2.24M |
|
1299
AGNC Investment
AGNC
$12.6B
| $1.26M | ﹤0.01% |
53,891
-16,509
| -23% | -$380K |
|
|
CYBX
1300
DELISTED
CYBERONICS INC
CYBX
| $1.26M | ﹤0.01% |
20,192
-17,705
| -47% | -$1.08M |
|
Similar funds
Allianz Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Allianz Asset Management held 2,085 positions worth $79.7B, down 4.3% from $83.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Allianz Asset Management withdrew a net $8.2B in Q2 2014, closing 145 positions and reducing 928 holdings. Its most notable exit was Pentair, an estimated $54.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Allianz Asset Management opened a new position in GSK worth $387M.
- Allianz Asset Management's largest Q2 2014 buy was GSK: 5,790,408 shares worth $387M.
- Allianz Asset Management added most to Verizon in Q2 2014, an estimated $361M increase.
- Allianz Asset Management's biggest Q2 2014 reduction was Bank of America Series L, cutting an estimated $4.92B.
- Allianz Asset Management fully exited Pentair in Q2 2014, selling an estimated $54.1M.
- Allianz Asset Management's ten largest holdings make up 14% of its $79.7B portfolio in Q2 2014.
- Allianz Asset Management opened 185 new positions and closed 145 in Q2 2014.
- Allianz Asset Management's portfolio value fell 4.3% quarter-over-quarter to $79.7B.
Based on Allianz Asset Management's 13F filing for Q2 2014, filed 13 Aug 2014.